Targets for anticancer drugs in estrogen-induced carcinogenesis
Conference ObjectAçık Erişim
Anahtar Kelimeler
RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/16995Resmi atıflarda kullanılan kalıcı adresTam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Gurer-Orhan, Hande | |
| dc.contributor.author | Ince, Elif | |
| dc.contributor.author | Ozcan, Senem | |
| dc.contributor.author | Shirinzadeh, Hanif Hanif | |
| dc.contributor.author | Suzen, Sibel | |
| dc.date.accessioned | 2026-10-18T20:41:11.988385857Z | |
| dc.date.available | 2026-10-18T20:41:11.988385857Z | |
| dc.date.issued | 2017 | |
| dc.description.sponsorship | This work was supported by The Scientific and Technological Research Council of Turkey (TUBITAK) Grant 109S099, 112S375, Ege University Research Project 13ECZ008. Analyses are performed at Ege University Faculty of Pharmacy, Pharmaceutical Sciences Research Center (FABAL). | |
| dc.identifier.doi | 10.1016/j.toxlet.2017.08.026 | |
| dc.identifier.eissn | 1879-3169 | |
| dc.identifier.endpage | S307 | |
| dc.identifier.issn | 0378-4274 | |
| dc.identifier.startpage | S307 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/16995 | |
| dc.identifier.volume | 280 | |
| dc.identifier.wos | WOS:000425486700776 | |
| dc.language.iso | en | |
| dc.publisher | ELSEVIER IRELAND LTD | |
| dc.relation.ispartof | TOXICOLOGY LETTERS | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Toxicology | |
| dc.title | Targets for anticancer drugs in estrogen-induced carcinogenesis | |
| dc.type | Conference Object | |
| dspace.entity.type | Publication | |
| rdl.citation.wos | 0 | |
| rdl.source.index | WOS | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) | |
| rdl.wos.index | Conference Proceedings Citation Index - Science (CPCI-S) |
